Allotrope Medical's Innovative Device Identify The Ureter To Prevent Injuries During Surgery

Allotrope Medical's Innovative Device Identify The Ureter To Prevent Injuries During Surgery

Millions of operations are performed every year that require identification of the ureters. Ureteral injuries cause increased pain and can result in permanent kidney damage, and even have the potential to be life threatening. It require additional procedures, delaying recovery and costing the healthcare system billions of dollars every year. Current approaches are costly and largely ineffective or inefficient, and as a result up to a third of operating time during minimally invasive surgeries are spent trying to identify the ureter.

The Houston-based startup Allotrope Medical is determined to decrease the rate of injury to the ureters during surgery. They have developed a handheld device, called the StimSite, which assist surgeons to quickly and easily identify the ureters during a procedure. The single-use, disposable device uses electrical stimulation, and with a single button activation it generates an easily visible contraction down the entire length of the ureter. This allow the surgeon to see the path of the ureter, avoid injuring it without spending additional time dissecting or having a urologist come in to place a stent.

Injury to the ureter during surgery have significant impact on patients’ lives. It increases recovery time and cost billions every year, posing a substantial burden on the healthcare system. Current techniques fall short of effectively addressing this issue. Allotrope Medical has developed an innovative technology that rapidly and accurately identify the ureter. The intuitive design of the device can prevent ureter injuries before they happen, avoiding additional extensive and expensive procedures that can carry their own risks. It will help avoid cystoscopy and urology consults, as well as tissue dissection, increasing surgical efficiency. Most importantly, the device will increase patient safety and outcomes, improving the surgical experience for patients, surgeons and staff.

Allotrope Medical was founded by CEO Albert Huang, who has over a decade of industrial design experience combined with tissue engineering and surgical training. The technology was invented and developed at the Texas Medical Center, and the startup has been part of TMCx, as well as Medtech Innovator 2017. Earlier in 2017, it was announced that Houston Health Ventures had invested an undisclosed amount in the startup together with Houston Angel Network. The Allotrope device is expected to be commercially available in late 2018, early 2019.